SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+16.1%
5Y CAGR+16.5%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+16.1%/yr
vs +23.1%/yr prior
5Y CAGR
+16.5%/yr
Consistent
Acceleration
-7.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$140.72B+16.0%
2024$121.35B+144.7%
2023$49.59B-44.8%
2022$89.85B+45.6%
2021$61.70B-5.9%
2020$65.55B+198.4%
2019$21.96B-43.8%
2018$39.07B-44.8%
2017$70.82B+4.6%
2016$67.69B-